US Navy Deploys Supercarrier USS George Washington in the IndoPacific Strategic and Market Implications
Kevin Warsh Set to Be Sworn In as Federal Reserve Chair on Friday
SP 500 Edges Higher as Consumer Staples and Discretionary Lead Tech Slips
Best HighYield Savings Interest Rates Today May 22 2026 Up to 410 APY Return
China Urges APEC Unity as Trade Minister Steps In for Absent Commerce Chief
Could SpaceXs MegaIPO Signal a Market Peak Analysts Weigh In
KZR Q1 2026 Earnings EPS Miss Highlights Cash Burn as Company Advances Pipeline
PTC Q1 2026 Earnings Strong EPS Beat Fuels Cautious Optimism Amid Slight Stock Dip
CUZ Q1 2026 Earnings EPS Beats Estimates by 155 Shares Edge Higher
Talphera Inc TLPH Q1 2026 Earnings Narrower Loss Surprises Analysts as Company Advances Pipeline
Lineage Cell Therapeutics Inc LCTX Q1 2026 Earnings Miss on EPS as ClinicalStage Biotech Continues Development
PPBT Q1 2025 Earnings Narrowing Losses and Pipeline Progress Drive Optimism
Rezolve AI Warrants RZLVW Stabilizes at 093 as Price Action Consolidates Between Key Levels
Vera Bradley VRA Slides 204 as Shares Test Support Near 319
Western Alliance Bancorporation Holds Steady Near 7859 as Consolidation Continues
Roadzen Warrants RDZNW Surge 23 Momentum Builds Above Key Support
Precision Optics POCI Moves Higher Amid Consolidation Support and Resistance Define Trading Range
Jobless Claims Remain at Historically Low Levels Signaling Labor Market Strength
Ingles Markets Q1 2026 Earnings EPS of 128 Supports Stock Gain Amid Limited Disclosure
ARKO Corp Holds Near Support Amid Modest Uptick
Winnebago Q1 2026 Earnings Operational Discipline Drives EPS Surprise Amid Subdued Demand
Cemtrex Inc CETX Q3 2024 Earnings EPS Misses Estimates as Loss Widens
Allot Ltd Q1 2026 Earnings EPS Beat Drives Stock Higher
LGND Q1 2026 Earnings EPS Misses Estimates but Stock Gains on Operational Strength
Data Storage Corporation DTST Q1 2026 Earnings Earnings Surprise Driven by NarrowerThanExpected Loss
OIS Q1 2026 Earnings EPS Slightly Exceeds Estimates Amid Mixed Market Conditions
C4 Therapeutics CCCC Q1 2026 Earnings Narrowing Losses Drive Surprise Beat Despite Zero Revenue